NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/sorrento-therapeutics-inc-loss-submission-form?prid=8049&wire=1
Lead Plaintiff Deadline: July 27, 2020
Class Period: May 15, 2020 - May 22, 2020
Allegations against SRNE include that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Forescout Technologies, Inc. (NASDAQ:FSCT)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/forescout-technologies-inc-loss-submission-form-2?prid=8049&wire=1
Lead Plaintiff Deadline: August 10, 2020
Class Period: February 6, 2020 - May 15, 2020
Allegations against FSCT include that: (1) Forescout was experiencing a significant and disproportionate decline in its financial performance; (2) the foregoing was reasonably likely to have a material negative impact on Forescout's planned acquisition by Advent International Corp.; and (3) as a result of the foregoing, defendants' statements about its business and operations were materially false and misleading at all relevant times.
J2 Global, Inc. (NASDAQ:JCOM)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/j2-global-inc-loss-submission-form?prid=8049&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: October 5, 2015 - June 29, 2020
Allegations against JCOM include that: (1) J2 Global engaged in undisclosed related party transactions; (2) J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions; (3) several so-called independent members of the Company' board of directors and audit committee were not disinterested; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong